Agios Pharmaceuticals
Erin Caffrey is an experienced finance professional currently serving as Manager of Revenue and Manager of SEC Reporting and Technical Accounting at Agios Pharmaceuticals since June 2018. Previous roles include Associate Manager of SEC Reporting at Agios Pharmaceuticals and FSO Assurance Senior specializing in Asset Management at EY from September 2014 to June 2018. Erin began the career as an Assurance Intern at Ernst & Young in June 2013. Erin holds a Bachelor of Science in Accounting from Virginia Tech, obtained in 2014, and graduated from Ridgewood High School in 2010.
Agios Pharmaceuticals
5 followers
Agios Pharmaceuticals Inc. is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway.